Consensus workshop on the toxic effects of long-term PUVA therapy

Archives of Dermatology

Volumn 134, Issue 5, 1998, Pages 595-598

  Morison, Warwick L ^a,n   Baughman, Richard D ^b   Day, Robert M ^k   Forbes, P Donald ^l   Hoenigsmann, Herbert ^m   Krueger, Gerald G ^c   Lebwohl, Mark ^d   Lew, Robert ^e   Naldi, Luigi ^h   Parrish, John A ^f   Piepkom, Michael ⁱ   Stern, Robert S ^g   Weinstein, Gerald D ^j   Whitmore, S Elizabeth ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d MOUNT SINAI MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k Clinicor Inc   (United States)

^l Argus Research Laboratories Inc   (United States)

^m MEDICAL UNIVERSITY OF VIENNA   (Austria)

ⁿ Johns Hopkins Green Spring   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ARTICLE; CANCER RISK; HUMAN; LONG TERM CARE; MELANOMA; PRIORITY JOURNAL; PSORIASIS; PUVA; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

HUMANS; MELANOMA; PSORIASIS; PUVA THERAPY; RISK; SKIN NEOPLASMS; TIME FACTORS;

EID: 17344366880     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.134.5.595     Document Type: Article

References (21)

1. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med. 1997;336:1041-1045.
2. Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974;291:1207-1211.
3. Melski JW, Tanenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL, and 28 participating investigators. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dematol. 1977;68:328-335.
4. Stern RS, Thibodeau LA, Kleinerman RA, Parrish JA, Fitzpatrick TB, and 22 participating investigators. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med. 1979;300: 809-813.
5. Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, Bleich HL. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med. 1984;310:1156-1161.
6. Stern RS, Lange R, and Members of the Photochemotherapy Follow-up Study. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol. 1988;91:120-124.
7. Stern RS, and Members of the Photochemotherapy Follow-Up Study. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med. 1990;322:1093-1097.
8. Stern RS, Laird N, for the Photochemotherapy Follow-Up Study. The carcinogenic risk of treatments for severe psoriasis. Cancer. 1994;73:2759-2764.
9. Lobel E, Paver K, King R, Le Quay JL, Poyzer K, Wargon O. The relationship of skin cancer to PUVA therapy in Australia. Australas J Dermatol. 1981;22:100-103.
10. Bruynzeel I, Bergman W, Hartevelt HM, et al. High single-dose European PUVA regimen also causes an excess of non-melanoma skin cancer. Br J Dermatol. 1991;124:49-55.
11. Lindelof B, Sigurgeirsson B, Tegner E, et al. PUVA and cancer: a large-scale epidemiological study. Lancet. 1991;338:91-93.
12. Chuang TY, Heinrich LA, Schultz MD, Reizner GT, Cripps DJ. PUVA and skin cancer. J Am Acad Dermatol. 1992;26:173-177.
13. Olsen JH, Moller H, Frentz G. Malignant tumors in patients with psoriasis. J Am Acad Dermatol. 1992;27:716-722.
14. Lever LR, Farr PM. Skin cancer or premalignant lesions occur in half of high-dose PUVA patients. Br J Dermatol. 1994;131:215-219.
15. McKenna KE, Patterson CC, Handley J, McGinn S, Allen G. Cutaneous neoplasia following PUVA therapy for psoriasis. Br J Dermatol. 1996;134:639-642.
16. Forman AB, Roenigk HH, Caro WA, Magid ML. Long-term follow-up of skin cancer in the PUVA-48 cooperative study. Arch Dermatol. 1989;125:515-519.
17. Lassus A, Renuala T, Idanpaan-Heikkila J, Juvakoski T, Salo O. PUVA treatment and skin cancer: a follow-up study. Acta Derm Venereol. 1981;61:141-145.
18. Eskelinen A, Halme K, Lassus A, Idanpaan-Heikkila J. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA. Photodermatology. 1985:2:10-14.
19. Henseler T, Christophers E, Honigsmann H, Wolff K, and 19 other investigators. Skin tumors in the European PUVA study. J Am Acad Dermatol. 1987; 16:108-116.
20. Tanew A, Honigsmann H, Ortel B, Zussner C, Wolff K. Nonmelanoma skin tumors in long-term photochemotherapy treatment of psoriasis. J Am Acad Dermatol. 1986;15:960-965.
21. Torinuki W, Tagami H. Incidence of skin cancer in Japanese psoriatic patients treated with either methoxsalen phototherapy, Goeckerman regimen, or both therapies. J Am Acad Dermatol. 1988; 18:1278-1281.